Chicago Bears Offseason Stock Watch: Danny Trevathan
Where is the stock trending on Chicago Bears linebacker Danny Trevathan?
The first case has to be made that Danny Trevathan’s stock is trending up. There was an argument to be made that Trevathan may not have been back with the Chicago Bears. He was a free agent this offseason and coming off of injury.
The Bears may have wanted to go in a different direction. The fact that they were interested enough to not only bring him back but sign him to a three-year extension with options to make it a longer deal.
Given his age and injury history, the expectation could have been a one year deal with minimum guarantees. Instead, Trevathan saw $13.6 million guaranteed. Not bad.
The Bears also do not have much depth. They are putting a lot of faith in Danny Trevathan having a good year. That is a good cause for his stock to be up.
Still, at this point, it is hard to trust Trevathan in the manner that the Chicago Bears are. Trevathan is not only going over the age of 30 apex and he not only is coming off of an injury. This is a player with a long history of injury-plagued seasons. In fact, he only played all 16 games for Chicago one time since he has been signed.
Projecting a Tarik Cohen extension. dark. Next
It could be argued that the Bears re-signing him and not having the adequate depth to anticipate an injury is an issue for the Bears and not Trevathan. The fact that Trevathan is locked into a starting salary for three more years is a win for Trevathan. However, until he proves he can stay healthy, his stock has to be declining.